Nordea Investment Management AB lessened its stake in Agilent Technologies, Inc. (NYSE:A – Free Report) by 5.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,774,119 shares of the medical research company’s stock after selling 106,321 shares during the period. Nordea Investment Management AB owned about 0.63% of Agilent Technologies worth $242,983,000 as of its most recent SEC filing.
• 3 International Stocks Most U.S. Investors Have Never Heard Of
Several other institutional investors and hedge funds also recently made changes to their positions in A. Capital A Wealth Management LLC increased its position in Agilent Technologies by 10,600.0% during the 2nd quarter. Capital A Wealth Management LLC now owns 214 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 212 shares during the period. Board of the Pension Protection Fund acquired a new position in shares of Agilent Technologies in the 4th quarter worth approximately $27,000. Davis Capital Management acquired a new position in shares of Agilent Technologies in the 3rd quarter worth approximately $28,000. Physician Wealth Advisors Inc. boosted its stake in shares of Agilent Technologies by 490.0% in the 3rd quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company’s stock valued at $30,000 after purchasing an additional 196 shares during the last quarter. Finally, State of Wyoming bought a new stake in shares of Agilent Technologies in the 2nd quarter valued at $35,000.
Agilent Technologies stock opened at $111.18 on Monday. The company has a market capitalization of $31.42 billion, a PE ratio of 24.54, a PEG ratio of 2.34 and a beta of 1.31. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $160.27. The firm’s fifty day moving average is $126.87 and its 200 day moving average is $135.47. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44.
• 2 Stocks With Governmental Tailwinds to Drive Them Higher
Agilent Technologies (NYSE:A – Get Free Report) last posted its quarterly earnings results on Wednesday, February 25th. The medical research company reported $1.36 EPS for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The company had revenue of $1.80 billion during the quarter, compared to analyst estimates of $1.81 billion. During the same quarter in the previous year, the business posted $1.31 earnings per share. The company’s revenue for the quarter was up 7.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, sell-side analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 22nd. Investors of record on Tuesday, March 31st will be paid a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Tuesday, March 31st. Agilent Technologies’s dividend payout ratio is 22.52%.
• Amprius Stock Is Flashing One Signal That Traders Rarely Ignore
A number of brokerages recently weighed in on A. Barclays lowered their target price on shares of Agilent Technologies from $165.00 to $150.00 and set an “overweight” rating for the company in a research note on Thursday, February 26th. JPMorgan Chase & Co. increased their price target on Agilent Technologies from $165.00 to $180.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. Weiss Ratings reissued a “hold (c+)” rating on shares of Agilent Technologies in a research report on Monday, December 29th. UBS Group dropped their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Finally, Evercore upgraded Agilent Technologies from an “in-line” rating to an “outperform” rating and upped their target price for the company from $155.00 to $160.00 in a research report on Monday, January 5th. Two analysts have rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, Agilent Technologies currently has an average rating of “Moderate Buy” and an average price target of $161.20.
Get Our Latest Stock Report on A
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
• Five stocks we like better than Agilent Technologies
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Should You Invest $1,000 in Agilent Technologies Right Now?
Before you consider Agilent Technologies, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Agilent Technologies wasn’t on the list.
While Agilent Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here…Read more by MarketBeat